×
About 2,068 results

ALLMedicine™ Alopecia Areata Center

Research & Reviews  995 results

Psychiatric Basics of Alopecia Areata in Pediatric Patients: Evaluation of Emotion Dysr...
https://doi.org/10.1111/jocd.14122
Journal of Cosmetic Dermatology; Altunisik N, Ucuz I et. al.

Apr 2nd, 2021 - Alopecia areata (AA) is a skin disease characterized by sudden onset hair loss. The relationship between psychiatric status and AA has not been fully elucidated. The aim of this study is to evaluate emotion dysregulation, somatization, depression,...

Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001176
Drug Design, Development and Therapy; Mahasaksiri T, Kositkuljorn C et. al.

Apr 1st, 2021 - Treatment of extensive or recalcitrant alopecia areata (AA) is a major clinical challenge. Even after thorough investigation of several medications, its treatment outcomes have remained unsatisfactory. While there is no US Food and Drug Administra...

A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of ...
https://doi.org/10.1016/j.jaad.2021.03.050
Journal of the American Academy of Dermatology; King B, Guttman-Yassky E et. al.

Mar 24th, 2021 - Alopecia areata (AA) is an autoimmune form of hair loss with limited treatments. To evaluate the efficacy and safety of the Janus kinase inhibitors ritlecitinib and brepocitinib in patients with AA with ≥50% scalp hair loss. Patients were randomiz...

Intralesional methotrexate versus triamcinolone acetonide for localized alopecia areata...
https://doi.org/10.1111/jocd.14090
Journal of Cosmetic Dermatology; Hamdino M, El-Barbary RA et. al.

Mar 22nd, 2021 - Multiple therapeutic modalities are available for alopecia areata (AA) but still a challenging disease with variable severity, recurrence, and a major cosmetic concern. Compare the effectiveness and safety of intralesional methotrexate (MTX) versu...

see more →

Clinicaltrials.gov  1,019 results

Psychiatric Basics of Alopecia Areata in Pediatric Patients: Evaluation of Emotion Dysr...
https://doi.org/10.1111/jocd.14122
Journal of Cosmetic Dermatology; Altunisik N, Ucuz I et. al.

Apr 2nd, 2021 - Alopecia areata (AA) is a skin disease characterized by sudden onset hair loss. The relationship between psychiatric status and AA has not been fully elucidated. The aim of this study is to evaluate emotion dysregulation, somatization, depression,...

Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001176
Drug Design, Development and Therapy; Mahasaksiri T, Kositkuljorn C et. al.

Apr 1st, 2021 - Treatment of extensive or recalcitrant alopecia areata (AA) is a major clinical challenge. Even after thorough investigation of several medications, its treatment outcomes have remained unsatisfactory. While there is no US Food and Drug Administra...

A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of ...
https://doi.org/10.1016/j.jaad.2021.03.050
Journal of the American Academy of Dermatology; King B, Guttman-Yassky E et. al.

Mar 24th, 2021 - Alopecia areata (AA) is an autoimmune form of hair loss with limited treatments. To evaluate the efficacy and safety of the Janus kinase inhibitors ritlecitinib and brepocitinib in patients with AA with ≥50% scalp hair loss. Patients were randomiz...

Intralesional methotrexate versus triamcinolone acetonide for localized alopecia areata...
https://doi.org/10.1111/jocd.14090
Journal of Cosmetic Dermatology; Hamdino M, El-Barbary RA et. al.

Mar 22nd, 2021 - Multiple therapeutic modalities are available for alopecia areata (AA) but still a challenging disease with variable severity, recurrence, and a major cosmetic concern. Compare the effectiveness and safety of intralesional methotrexate (MTX) versu...

see more →

News  53 results

Alopecia Patients May Be at Increased Risk of Heart Attack
https://www.medscape.com/viewarticle/930946

May 21st, 2020 - NEW YORK (Reuters Health) - Patients with alopecia areata (AA) appear to be at heightened risk of acute myocardial infarction (AMI), according to a large population-based study from South Korea. "Our findings possibly imply that AA is not an autoi...

Alopecia Patients May Be at Increased Risk of Heart Attack
https://www.staging.medscape.com/viewarticle/930946

May 21st, 2020 - NEW YORK (Reuters Health) - Patients with alopecia areata (AA) appear to be at heightened risk of acute myocardial infarction (AMI), according to a large population-based study from South Korea. "Our findings possibly imply that AA is not an autoi...

Dermatology therapies evolve as disease knowledge and investment grow
https://www.mdedge.com/dermatology/article/219314/medical-dermatology/dermatology-therapies-evolve-disease-knowledge-and/page/0/2?channel=27980

Mar 19th, 2020 - Spillover to other diseases JAK inhibitors – some in oral and some in topical form – are showing efficacy in ongoing research for alopecia areata (AA) and vitiligo as well, Dr. Blauvelt said.

Pitting of fingernails
https://www.mdedge.com/familymedicine/article/215178/dermatology/pitting-fingernails?channel=203
MDedge Family Medicine;

Jan 23rd, 2020 - Given the constellation of non-scarring alopecia on the patient’s posterior scalp (with no scale, papules, or plaques), the physician diagnosed alopecia areata (AA) with associated nail pitting in this patient. Although a scalp biopsy could have c.

The Case of the Disappearing Eyebrows
https://www.mdedge.com/clinicianreviews/article/195335/dermatology/case-disappearing-eyebrows/page/0/1?channel=203

Feb 28th, 2019 - DISCUSSION This case illustrates several variants of an extremely common condition: alopecia areata (AA), literally translated as “hair loss confined to a particular localized area or areas. ” Although AA is more common in adults, it often affects.

see more →

Patient Education  1 results see all →